Melissa Holloway

Melissa Holloway

Runner-up in the 2017 IPSE Inspire Awards

Runner-up in the 2017 IPSE Inspire Awards


Speaking Diabetes is a diabetes-focussed training and consulting company based in London. 

Over 13 years of industry experience
Over 20 years of personal experience

Melissa Holloway, founder of Speaking Diabetes, embarked on a career in the healthcare industry as a writer for Close Concerns in 2003. She worked in the global headquarters of Abbott Diabetes Care (Alameda, California) from December 2005 until September 2007, and moved to London to begin work at Datamonitor in October of that year. There she was a healthcare business consultant and analyst in immunology and inflammatory disease for two years. She joined TBWA\Paling Walters (now TBWA\WorldHealth London) as a medical copywriter in 2009. After 4 years with TBWA, she went freelance in 2014 and has worked with more than a dozen advertising agencies on a contract basis.

Melissa has collaborated on several journal articles and clinical guidelines in diabetes (see Selected Publications below). In her part-time role as Chief Adviser with INPUT Patient Advocacy, the UK charity supporting patient access to diabetes technology, Melissa advises and supports enquirers and works on policy issues. She is also a service user representative on the NHS London Diabetes Clinical Leadership Group and a volunteer for JDRF

Melissa was born and raised in Fredericksburg, Virginia, USA. She was diagnosed with type 1 diabetes at age 12 in 1993. After graduating from Mary Baldwin College (now Mary Baldwin University; Staunton, Virginia) in 1999 (BA cum laude, with distinction in philosophy/religion, Phi Beta Kappa), she pursued a master’s in theology at The University of the South (Sewanee, Tennessee). Melissa continued her education at Oxford University, where she gained a master’s in historical research. 

Melissa lives in central London with her husband and son.

Selected publications

Continuous Glucose Monitoring Summit: white paper, American Association of Diabetes Educators, June 2015

Real-time continuous glucose monitoring in type 1 diabetes: a qualitative framework analysis of patient narratives, Diabetes Care, April 2015

Insulin Pump Therapy: best practices in choosing and using infusion devices, American Association of Diabetes Educators, November 2011

Insulin Pump Therapy: guidelines for successful outcomes, American Association of Diabetes Educators, March 2009

How Do the New Insulin Analogues Affect the Care of Your Patients? Diabetes Health magazine, Professional Edition, April 2006

It’s Not a Beeper, It’s My Insulin Pump, Medscape Diabetes & Endocrinology, July 2003